COVID-19 vaccination in Norway

COVID-19 vaccination in Norway
Date27 December 2020 (2020-12-27) – present
CauseCOVID-19 pandemic in Norway

COVID-19 vaccination in Norway is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. As of 3 January 2022 79,5% of the population have been vaccinated with the first dose, 72,7% with the second dose and 28,8% with the third dose (also known as the first booster dose).[1]

As of January 2022 the country offers both the Pfizer-BioNTech and Moderna vaccine for the population over 18 years old. It is possible for the population to choose the vaccine they want, and it is also possible to take different vaccines for the different doses. However, children under 18 years old are only given the Pfizer-BioNTech vaccine. The children under 15 years old need parental approval to be vaccinated, and they only get 1 dose of the Pfizer-BioTech vaccine. If they have some serious sickness, they may also get 2 doses. Only the children between 5 and 11 years old that have some serious sickness, will be offered the vaccine.[2] Men between 18 and 30 years old are also recommended to choose to take the Pfizer-BioNTech due to the higher risk of getting myocarditis and pericarditis with the Moderna vaccine.[3]

Norway is also closely monitoring side effects, with both reports from healthcare professionals and the public being registered in a common database. This should allow for a good overview of the situation once the vaccine is distributed in the general population, as well as an efficient collaboration with other countries. [4][5]

In May 2021, an expert review commissioned by the Norwegian Medicines Agency to investigate "the cause of the first 100 reported deaths of nursing home residents who had received the Pfizer-BioNTech vaccine" concluded that "a causal link between the Pfizer-BioNTech vaccine and death was considered “likely” in 10 of the 100 cases, “possible” in 26 cases, and “unlikely” in 59 cases. The remaining five were deemed “unclassifiable.”"[6]

Vaccines on order

There are several COVID-19 vaccines at various stages of development around the world.

Pfizer–BioNTechGreen check.svg 21 December 2020Green check.svg 27 December 2020
ModernaGreen check.svg 6 January 2021Green check.svg 12 January 2021
Oxford-AstraZenecaGreen check.svg 29 January 2021Green check.svg 7 February 2021
JanssenGreen check.svg 11 March 2021Green check.svg 5 May 2021
NovavaxGreen check.svg 20 December 2021Pending


  1. ^ {{cite web}}: Missing or empty |title= (help)
  2. ^ {{cite web}}: Missing or empty |title= (help)
  3. ^ {{cite web}}: Missing or empty |title= (help)
  4. ^ "International interest about deaths following coronavirus vaccination". Norwegian Institute of Public Health.
  5. ^ "Reported suspected adverse reactions of covid-19 vaccines". Statens legemiddelverk.
  6. ^ Torjesen, Ingrid (May 27, 2021). "Covid-19: Pfizer-BioNTech vaccine is "likely" responsible for deaths of some elderly patients, Norwegian review finds". BMJ. 373: n1372. doi:10.1136/bmj.n1372. ISSN 1756-1833. PMID 34045236. S2CID 235204094.

Media files used on this page

Coronavirus. SARS-CoV-2.png
Author/Creator: Alexey Solodovnikov (Idea, Producer, CG, Editor), Valeria Arkhipova (Scientific Сonsultant), Licence: CC BY-SA 4.0
Scientifically accurate atomic model of the external structure of the Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2), a strain (genetic variant) of the coronavirus that caused Coronavirus disease (COVID-19), first identified in Wuhan, China, during December 2019

Each separate locus (amorphous blob) is an atom of:

  cobalt: membrane
  crimson: E protein
  green: M protein
  orange: glucose (glycan)
  turquoise : S (spike) glycoprotein
SARS-CoV-2 (Wikimedia colors).svg
Author/Creator: Geraki, Licence: CC BY-SA 4.0
SARS-CoV-2 logo in Wikimedia colors
Green check.svg
Green check icon